You are here: Industry Insights > cancer

News List

Skin Cancer Awareness Month: overcoming drug resistance in skin cancer pharmaceutical-technology
May 13, 2019
Skin Cancer Awareness Month aims to raise awareness about prevention measures against the most common form of cancer. The death rates from skin cancers, particularly melanoma, continue to rise, largely due to the resistance of tumours to existing drugs.
CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer americanpharmaceuticalreview
May 10, 2019
CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer.
ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035 drugs
May 10, 2019
ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035.
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer worldpharmanews
May 10, 2019
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer.
Prostate cancer mutation found to triple risk of death pharmatimes
May 09, 2019
Prostate cancer mutation found to triple risk of death.
Raman scattering for non-invasive prostate cancer screening europeanpharmaceuticalreview
May 07, 2019
Raman scattering for non-invasive prostate cancer screening.
Novartis & Bristol-Myers Squibb to collaborate on cancer treatments europeanpharmaceuticalreview
May 07, 2019
Novartis has entered into a research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist…
New imaging technique may predict the spread of breast cancer europeanpharmaceuticalreview
May 06, 2019
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung…
Z-endoxifen shows promise for breast cancer europeanpharmaceuticalreview
May 06, 2019
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer…
Good news for AZ's 'next phase of growth': Its cancer drugs have shifted into high gear fiercepharma
May 06, 2019
For the first time, AstraZeneca's top-selling medicine isn't a stomach drug or a respiratory inhaler or any other primary care med. It's a cancer drug.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page